Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Prevention of aerosol isolation of nontuberculous mycobacterium from the patient's bathroom.

Morimoto K, Aono A, Murase Y, Sekizuka T, Kurashima A, Takaki A, Sasaki Y, Igarashi Y, Chikamatsu K, Goto H, Yamada H, Kuroda M, Mitarai S.

ERJ Open Res. 2018 Jul 3;4(3). pii: 00150-2017. doi: 10.1183/23120541.00150-2017. eCollection 2018 Jul.

2.

Mycobacterium triplex pulmonary disease with acquired macrolide resistance in immunocompetent patients.

Matsuda S, Suzuki S, Morimoto K, Aono A, Nishio K, Asakura T, Sasaki Y, Namkoong H, Nishimura T, Ogata H, Hasegawa N, Kurashima A, Ishii M, Tatsumi K, Mitarai S, Goto H.

Clin Microbiol Infect. 2018 Jun;24(6):671-672. doi: 10.1016/j.cmi.2017.12.018. Epub 2018 Jan 5. No abstract available.

PMID:
29309938
3.

Evaluation of PyroMark Q24 pyrosequencing as a method for the identification of mycobacteria.

Chikamatsu K, Aono A, Hata H, Igarashi Y, Takaki A, Yamada H, Sakashita K, Mitarai S.

Diagn Microbiol Infect Dis. 2018 Jan;90(1):35-39. doi: 10.1016/j.diagmicrobio.2017.09.002. Epub 2017 Sep 15.

PMID:
29107416
4.

Prediction of Local Transmission of Mycobacterium tuberculosis Isolates of a Predominantly Beijing Lineage by Use of a Variable-Number Tandem-Repeat Typing Method Incorporating a Consensus Set of Hypervariable Loci.

Murase Y, Izumi K, Ohkado A, Aono A, Chikamatsu K, Yamada H, Igarashi Y, Takaki A, Mitarai S.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01016-17. doi: 10.1128/JCM.01016-17. Print 2018 Jan.

5.

Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Miyake N, Chong Y, Nishida R, Takenaka K, Kato K, Miyamoto T, Aono A, Takaki A, Mitarai S, Shimoda S, Shimono N, Akashi K.

J Infect Chemother. 2018 Jan;24(1):78-81. doi: 10.1016/j.jiac.2017.08.011. Epub 2017 Oct 6.

PMID:
28988958
6.

Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.

Igarashi Y, Chikamatsu K, Aono A, Yi L, Yamada H, Takaki A, Mitarai S.

Diagn Microbiol Infect Dis. 2017 Dec;89(4):276-281. doi: 10.1016/j.diagmicrobio.2017.08.016. Epub 2017 Aug 25.

PMID:
28974394
7.

In vitro activity of sitafloxacin against Mycobacterium tuberculosis with gyrA/B mutations isolated in Japan.

Yi L, Aono A, Chikamatsu K, Igarashi Y, Yamada H, Takaki A, Mitarai S.

J Med Microbiol. 2017 Jun 9. doi: 10.1099/jmm.0.000493. [Epub ahead of print]

PMID:
28598311
8.

Factors contribute to efficiency of specimen concentration of Mycobacterium tuberculosis by centrifugation and magnetic beads.

Yoshimatsu S, Kato-Matsumaru T, Aono A, Chikamatsu K, Yamada H, Mitarai S.

Int J Mycobacteriol. 2015 Sep;4(3):245-9. doi: 10.1016/j.ijmyco.2015.05.014. Epub 2015 Jun 25.

9.

Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan.

Yi L, Sasaki Y, Nagai H, Ishikawa S, Takamori M, Sakashita K, Saito T, Fukushima K, Igarashi Y, Aono A, Chikamatsu K, Yamada H, Takaki A, Mori T, Mitarai S.

Sci Rep. 2016 Jul 29;6:30617. doi: 10.1038/srep30617.

10.

Successful Treatment of Peritoneal Dialysis-related Peritonitis due to Mycobacterium iranicum.

Inagaki K, Mizutani M, Nagahara Y, Asano M, Masamoto D, Sawada O, Aono A, Chikamatsu K, Mitarai S.

Intern Med. 2016;55(14):1929-31. doi: 10.2169/internalmedicine.55.5219. Epub 2016 Jul 15.

11.

Six Cases of Pulmonary Mycobacterium shinjukuense Infection at a Single Hospital.

Takeda K, Ohshima N, Nagai H, Sato R, Ando T, Kusaka K, Kawashima M, Masuda K, Matsui H, Aono A, Chikamatsu K, Mitarai S, Ohta K.

Intern Med. 2016;55(7):787-91. doi: 10.2169/internalmedicine.55.5460. Epub 2016 Apr 1.

12.

COBAS® TaqMan® MTB, smear positivity grade and MGIT culture; correlation analyses of three methods for bacillary quantification.

Chikamatsu K, Aono A, Kato T, Takaki A, Yamada H, Sasaki Y, Izumi K, Yi L, Mitarai S.

J Infect Chemother. 2016 Jan;22(1):19-23. doi: 10.1016/j.jiac.2015.09.005. Epub 2015 Oct 31.

PMID:
26527538
13.

Disseminated Mycobacterium abscessus Infection Following Septic Arthritis: A Case Report and Review of the Literature.

Fukui S, Sekiya N, Takizawa Y, Morioka H, Kato H, Aono A, Chikamatsu K, Mitarai S, Kobayashi S, Kamei S, Setoguchi K.

Medicine (Baltimore). 2015 May;94(21):e861. doi: 10.1097/MD.0000000000000861.

14.

Structome analysis of virulent Mycobacterium tuberculosis, which survives with only 700 ribosomes per 0.1 fl of cytoplasm.

Yamada H, Yamaguchi M, Chikamatsu K, Aono A, Mitarai S.

PLoS One. 2015 Jan 28;10(1):e0117109. doi: 10.1371/journal.pone.0117109. eCollection 2015.

15.

Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis.

Aono A, Chikamatsu K, Yamada H, Kato T, Mitarai S.

Antimicrob Agents Chemother. 2014 Aug;58(8):4928-30. doi: 10.1128/AAC.02394-14. Epub 2014 May 27.

16.

Optimization of the microscopic observation drug susceptibility assay for four first-line drugs using Mycobacterium tuberculosis reference strains and clinical isolates.

Nishiyama H, Aono A, Sugamoto T, Mizuno K, Chikamatsu K, Yamada H, Mitarai S.

J Microbiol Methods. 2014 Jun;101:44-8. doi: 10.1016/j.mimet.2014.03.014. Epub 2014 Apr 6.

PMID:
24717372
17.

[Evaluation of the use of SPEED-OLIGO Mycobacteria for identification of Mycobacterium species].

Chikamatsu K, Aono A, Yamada H, Kato T, Mitarai S.

Kekkaku. 2014 Feb;89(2):45-50. Japanese.

PMID:
24716358
18.

Comparative evaluation of three immunochromatographic identification tests for culture confirmation of Mycobacterium tuberculosis complex.

Chikamatsu K, Aono A, Yamada H, Sugamoto T, Kato T, Kazumi Y, Tamai K, Yanagisawa H, Mitarai S.

BMC Infect Dis. 2014 Feb 1;14:54. doi: 10.1186/1471-2334-14-54.

19.
20.

Sub-speciation of Mycobacterium tuberculosis complex from tuberculosis patients in Japan.

Ueyama M, Chikamatsu K, Aono A, Murase Y, Kuse N, Morimoto K, Okumura M, Yoshiyama T, Ogata H, Yoshimori K, Kudoh S, Azuma A, Gemma A, Mitarai S.

Tuberculosis (Edinb). 2014 Jan;94(1):15-9. doi: 10.1016/j.tube.2013.09.006. Epub 2013 Oct 9.

PMID:
24183617
21.

Dynamics of intracellular phospholipid membrane organization during oocyte maturation and successful vitrification of immature oocytes retrieved by ovum pick-up in cattle.

Aono A, Nagatomo H, Takuma T, Nonaka R, Ono Y, Wada Y, Abe Y, Takahashi M, Watanabe T, Kawahara M.

Theriogenology. 2013 May;79(8):1146-1152.e1. doi: 10.1016/j.theriogenology.2013.02.009. Epub 2013 Mar 25.

PMID:
23534997
22.
23.

[Mycobacterium immunogenum isolated from a metal worker in Japan].

Omura H, Kajiki A, Ikegame S, Aono A, Mitarai S, Kitahara Y.

Kekkaku. 2012 Apr;87(4):341-4. Japanese.

PMID:
22702082
24.

TRICORE, a novel bead-based specimen concentration method for the culturing of Mycobacterium tuberculosis.

Mitarai S, Karinaga R, Yamada H, Mizuno K, Chikamatsu K, Aono A, Sugamoto T, Hatano T.

J Microbiol Methods. 2012 Sep;90(3):152-5. doi: 10.1016/j.mimet.2012.04.018. Epub 2012 May 2.

PMID:
22579580
25.

Non-acid-fastness in Mycobacterium tuberculosis ΔkasB mutant correlates with the cell envelope electron density.

Yamada H, Bhatt A, Danev R, Fujiwara N, Maeda S, Mitarai S, Chikamatsu K, Aono A, Nitta K, Jacobs WR Jr, Nagayama K.

Tuberculosis (Edinb). 2012 Jul;92(4):351-7. doi: 10.1016/j.tube.2012.02.006. Epub 2012 Apr 18.

PMID:
22516756
26.

Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis.

Mitarai S, Kato S, Ogata H, Aono A, Chikamatsu K, Mizuno K, Toyota E, Sejimo A, Suzuki K, Yoshida S, Saito T, Moriya A, Fujita A, Sato S, Matsumoto T, Ano H, Suetake T, Kondo Y, Kirikae T, Mori T.

J Clin Microbiol. 2012 Mar;50(3):884-90. doi: 10.1128/JCM.05638-11. Epub 2012 Jan 11.

27.

Evaluation of a simple loop-mediated isothermal amplification test kit for the diagnosis of tuberculosis.

Mitarai S, Okumura M, Toyota E, Yoshiyama T, Aono A, Sejimo A, Azuma Y, Sugahara K, Nagasawa T, Nagayama N, Yamane A, Yano R, Kokuto H, Morimoto K, Ueyama M, Kubota M, Yi R, Ogata H, Kudoh S, Mori T.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1211-7, i. doi: 10.5588/ijtld.10.0629.

PMID:
21943848
28.

[Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains].

Chikamatsu K, Mizuno K, Aono A, Yamada H, Sugamoto T, Nishiyama H, Mitarai S.

Kekkaku. 2011 Jul;86(7):697-702. Japanese.

PMID:
21922778
29.

Improved polyacrylamide-based artificial sputum with formalin-fixed tubercle bacilli for training of tuberculosis microscopists.

Yamada H, Mitarai S, Wahyunitisari MR, Mertaniasih NM, Sugamoto T, Chikamatsu K, Aono A, Matsumoto H, Fujiki A.

J Clin Microbiol. 2011 Oct;49(10):3604-9. doi: 10.1128/JCM.00370-11. Epub 2011 Aug 3.

30.

[Non-tuberculous mycobacterium strains that show positive test for identification kits of M. tuberculosis complex].

Aono A, Kazumi Y, Maeda S, Azuma Y, Tsuchiya S, Iwamoto T, Nakanaga K, Hayakawa K, Saito H.

Kekkaku. 2010 May;85(5):461-4. Japanese.

PMID:
20560401
31.

[Clinical evaluation of acid-fast smear examination with light emitting diode fluorescent microscopy].

Mizuno K, Chikamatsu K, Aono A, Azuma Y, Yamada H, Mitarai S.

Kekkaku. 2009 Sep;84(9):627-9. Japanese.

PMID:
19860265
32.

Rapid prediction of BACTEC MGIT 960 culture results by COBAS amplicor mycobacterium polymerase chain reaction detection.

Aono A, Azuma Y, Mitarai S, Ogata H.

Diagn Microbiol Infect Dis. 2009 May;64(1):27-30. doi: 10.1016/j.diagmicrobio.2009.01.011.

PMID:
19362257
33.

Effects of tributyltin at concentrations below ambient levels in seawater on Caprella danilevskii (Crustacea: Amphipoda: Caprellidae).

Aono A, Takeuchi I.

Mar Pollut Bull. 2008;57(6-12):515-23. doi: 10.1016/j.marpolbul.2008.02.031. Epub 2008 May 12.

PMID:
18468647
34.

[Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].

Yoshiyama T, Ogata H, Ito K, Aono A, Wada M.

Kekkaku. 2007 Feb;82(2):95-101. Japanese.

PMID:
17373318
35.

[Number of sputum cultures by MGIT system needed to diagnose pulmonary tuberculosis].

Ito K, Aono A, Yoshiyama T, Wada M, Ogata H.

Kekkaku. 2006 Aug;81(8):511-8. Japanese.

PMID:
16972654
36.
37.

[Should chemotherapy for pulmonary tuberculosis be started after the completion of pretreatment sputum examination?].

Ito K, Aono A, Yoshiyama T, Wada M, Ogata H.

Kekkaku. 2005 Dec;80(12):735-41. Japanese.

PMID:
16447786
38.

[Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis].

Yoshiyama T, Ito K, Ogata H, Aono A, Wada M.

Kekkaku. 2005 Jan;80(1):9-14. Japanese.

PMID:
15839057
39.

[Process of acquiring drug resistance: retrospective review of records of MDR TB].

Yoshiyama T, Ito K, Ogata H, Mitarai S, Hoshino H, Okumura M, Aman K, Aono A, Wada M.

Kekkaku. 2004 Dec;79(12):717-24. Japanese.

PMID:
15782617
40.
42.

Effect of herpes simplex virus-1 gD or gD-IL-2 DNA vaccine on herpetic keratitis.

Inoue T, Inoue Y, Hayashi K, Shimomura Y, Fujisawa Y, Aono A, Tano Y.

Cornea. 2002 Oct;21(7 Suppl):S79-85.

PMID:
12484704
43.

The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis.

Inoue T, Inoue Y, Nakamura T, Yoshida A, Inoue Y, Tano Y, Shimomura Y, Fujisawa Y, Aono A, Hayashi K.

Jpn J Ophthalmol. 2002 Jul-Aug;46(4):370-76.

PMID:
12225814
44.

Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.

Inoue T, Inoue Y, Hayashi K, Yoshida A, Nishida K, Shimomura Y, Fujisawa Y, Aono A, Tano Y.

Cornea. 2002 Jan;21(1):106-10.

PMID:
11805518
46.

Convenient dioxin measuring method using an efficient sampling train, an efficient HPLC system and a highly sensitive HRGC/LRMS with a PTV injector.

Urano K, Kato M, Nagayanagi Y, Saito Y, Aono A, Nagata J, Syudo H.

Chemosphere. 2001 May-Jun;43(4-7):425-31.

PMID:
11372822
47.

[The effect of immunization with herpes simplex virus glycoprotein D fused with interluekin-2 against murine herpetic keratitis].

Inoue T, Inoue Y, Nakamura T, Yoshida A, Inoue Y, Tano Y, Shimomura Y, Fujisawa Y, Aono A, Hayashi K.

Nippon Ganka Gakkai Zasshi. 2001 Apr;105(4):223-9. Japanese.

PMID:
11329945
48.

[Participation of pharmacists in the medical team at home].

Tsuzuki I, Kiyotoshi Y, Uno H, Fujimoto I, Aono A.

Gan To Kagaku Ryoho. 2000 Dec;27 Suppl 3:675-8. Japanese.

PMID:
11190319
49.

Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.

Inoue T, Inoue Y, Nakamura T, Yoshida A, Takahashi K, Inoue Y, Shimomura Y, Tano Y, Fujisawa Y, Aono A, Hayashi K.

Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4209-15.

PMID:
11095617

Supplemental Content

Support Center